AI-driven diagnostics company predicting cancer treatment response from pathology slides.
About
Valar Labs develops AI-powered diagnostics that analyze pathology slides to predict cancer treatment response. Their technology, exemplified by the Vesta platform for bladder cancer, aims to reduce uncertainty in treatment decisions and personalize care for patients. The company collaborates with healthcare providers and pharmaceutical companies to advance precision oncology.
Tags
Total Employees
28
Current headcount
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Valar AI do?
Valar Labs develops AI-powered diagnostics that analyze pathology slides to predict cancer treatment response. Their technology, exemplified by the Vesta platform for bladder cancer, aims to reduce uncertainty in treatment decisions and personalize care for patients. The company collaborates with healthcare providers and pharmaceutical companies to advance precision oncology.
How much funding has Valar AI raised?
Valar AI has raised a total of $2.4B in funding. The most recent round on record is Series A.
Where is Valar AI headquartered?
Valar AI is headquartered in New York, United States.
When was Valar AI founded?
Valar AI was founded in 2010.
What industry does Valar AI operate in?
Valar AI operates in Fintech, Venture Capital, Payments, Digital Payments, Financial Services, Investment Firm.
How many employees does Valar AI have?
Valar AI has approximately 28 people on record.
What is Valar AI's current status?
Valar AI's current operating status is: Acquired.